Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Engineering of a miniaturized, robotic clinical laboratory.

Nourse MB, Engel K, Anekal SG, Bailey JA, Bhatta P, Bhave DP, Chandrasekaran S, Chen Y, Chow S, Das U, Galil E, Gong X, Gessert SF, Ha KD, Hu R, Hyland L, Jammalamadaka A, Jayasurya K, Kemp TM, Kim AN, Lee LS, Liu YL, Nguyen A, O'Leary J, Pangarkar CH, Patel PJ, Quon K, Ramachandran PL, Rappaport AR, Roy J, Sapida JF, Sergeev NV, Shee C, Shenoy R, Sivaraman S, Sosa-Padilla B, Tran L, Trent A, Waggoner TC, Wodziak D, Yuan A, Zhao P, Young DL, Robertson CR, Holmes EA.

Bioeng Transl Med. 2018 Jan 19;3(1):58-70. doi: 10.1002/btm2.10084. eCollection 2018 Jan.

2.

SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm.

Hamblett KJ, Jacob AP, Gurgel JL, Tometsko ME, Rock BM, Patel SK, Milburn RR, Siu S, Ragan SP, Rock DA, Borths CJ, O'Neill JW, Chang WS, Weidner MF, Bio MM, Quon KC, Fanslow WC.

Cancer Res. 2015 Dec 15;75(24):5329-40. doi: 10.1158/0008-5472.CAN-15-1610. Epub 2015 Dec 2.

3.

Sphingosine kinase activity is not required for tumor cell viability.

Rex K, Jeffries S, Brown ML, Carlson T, Coxon A, Fajardo F, Frank B, Gustin D, Kamb A, Kassner PD, Li S, Li Y, Morgenstern K, Plant M, Quon K, Ruefli-Brasse A, Schmidt J, Swearingen E, Walker N, Wang Z, Watson JE, Wickramasinghe D, Wong M, Xu G, Wesche H.

PLoS One. 2013 Jul 5;8(7):e68328. doi: 10.1371/journal.pone.0068328. Print 2013.

4.

Measurement of Cancer Cell Growth Heterogeneity through Lentiviral Barcoding Identifies Clonal Dominance as a Characteristic of In Vivo Tumor Engraftment.

Nolan-Stevaux O, Tedesco D, Ragan S, Makhanov M, Chenchik A, Ruefli-Brasse A, Quon K, Kassner PD.

PLoS One. 2013 Jun 26;8(6):e67316. doi: 10.1371/journal.pone.0067316. Print 2013.

5.

STK33 kinase activity is nonessential in KRAS-dependent cancer cells.

Babij C, Zhang Y, Kurzeja RJ, Munzli A, Shehabeldin A, Fernando M, Quon K, Kassner PD, Ruefli-Brasse AA, Watson VJ, Fajardo F, Jackson A, Zondlo J, Sun Y, Ellison AR, Plewa CA, San MT, Robinson J, McCarter J, Schwandner R, Judd T, Carnahan J, Dussault I.

Cancer Res. 2011 Sep 1;71(17):5818-26. doi: 10.1158/0008-5472.CAN-11-0778. Epub 2011 Jul 8.

6.

Use of cryopreserved cell aliquots in the high-throughput screening of small interfering RNA libraries.

Swearingen EA, Fajardo F, Wang X, Watson JE, Quon KC, Kassner PD.

J Biomol Screen. 2010 Jun;15(5):469-77. doi: 10.1177/1087057110365899. Epub 2010 Apr 6.

PMID:
20371867
7.

RNA interference screening for the discovery of oncology targets.

Quon K, Kassner PD.

Expert Opin Ther Targets. 2009 Sep;13(9):1027-35. doi: 10.1517/14728220903179338. Review.

PMID:
19650760
8.

A functional screen for regulators of CKDN2A reveals MEOX2 as a transcriptional activator of INK4a.

Irelan JT, Gutierrez Del Arroyo A, Gutierrez A, Peters G, Quon KC, Miraglia L, Chanda SK.

PLoS One. 2009;4(4):e5067. doi: 10.1371/journal.pone.0005067. Epub 2009 Apr 2.

9.

A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function.

Rottmann S, Wang Y, Nasoff M, Deveraux QL, Quon KC.

Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15195-200. Epub 2005 Oct 6.

10.

RAS, MYC, and sensitivity to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis.

Wang Y, Quon KC, Knee DA, Nesterov A, Kraft AS.

Cancer Res. 2005 Feb 15;65(4):1615-6; author reply 1616-7. No abstract available.

11.

Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway.

Wang Y, Engels IH, Knee DA, Nasoff M, Deveraux QL, Quon KC.

Cancer Cell. 2004 May;5(5):501-12.

12.

Identification of p53 regulators by genome-wide functional analysis.

Huang Q, Raya A, DeJesus P, Chao SH, Quon KC, Caldwell JS, Chanda SK, Izpisua-Belmonte JC, Schultz PG.

Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3456-61. Epub 2004 Feb 27.

13.

Haplo-insufficiency? Let me count the ways.

Quon KC, Berns A.

Genes Dev. 2001 Nov 15;15(22):2917-21. Review. No abstract available.

14.

Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.

Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A.

Nature. 2001 Sep 6;413(6851):83-6.

PMID:
11544530
15.

Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate.

Goldberg SF, Harms JF, Quon K, Welch DR.

Clin Exp Metastasis. 1999;17(7):601-7.

PMID:
10845559
16.

CSH Meeting on Cancer Genetics 1998.

Quon K, Berns A.

Biochim Biophys Acta. 1999 Mar 25;1423(2):R53-61. No abstract available.

PMID:
10214351
17.
18.

Negative control of bacterial DNA replication by a cell cycle regulatory protein that binds at the chromosome origin.

Quon KC, Yang B, Domian IJ, Shapiro L, Marczynski GT.

Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):120-5.

20.

The control of temporal and spatial organization during the Caulobacter cell cycle.

Domian IJ, Quon KC, Shapiro L.

Curr Opin Genet Dev. 1996 Oct;6(5):538-44. Review.

PMID:
8939718
21.

Cell cycle control by an essential bacterial two-component signal transduction protein.

Quon KC, Marczynski GT, Shapiro L.

Cell. 1996 Jan 12;84(1):83-93.

22.

Supplemental Content

Support Center